Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Geneticists find cause of cerebellar ataxia
"...the research has confirmed that we do still have carrier dogs in the present population, meaning an affected puppy could arise at any time."
DNA test now available for Norwegian buhunds  

Scientists at the Animal Health Trust (AHT) have identified a genetic mutation that is responsible for cerebellar ataxia in Norwegian buhunds.

A DNA test is now available from the trust, to help breeders identify carriers and prevent the disease being passed down to puppies.

Cerebellar ataxia can affect dogs from just 12 weeks of age, causing uncoordinated movement and head tremors. The disease is progressive but there is currently no effective treatment available, meaning affected animals are often euthanised on welfare grounds.

The breed’s health co-ordinator, Margaret Deuchar, commented: “Although we have not been aware of any clinically affected puppies in the last few years the research has confirmed that we do still have carrier dogs in the present population, meaning an affected puppy could arise at any time.

“With the DNA test now available we can prevent another puppy suffering this horrendous condition and hopefully over a number of years progressively reduce the prevalence of the mutant recessive gene - without making our numerically small gene pool even smaller, and thus putting the breed at increased risk of different genetic diseases.”

Geneticists tested 146 Norwegian buhunds - who were not showing signs of cerebellar ataxia - for the causative mutation. The group of 146 dogs consisted of 70 UK dogs (from which samples were collected between 2008-2015), 36 UK dogs (from which samples were collected in 2017) and 40 dogs from Finland (born 1998-2012).

The first UK set of dogs (2008-2015) included significantly more carriers than the other two sets, but carriers of the mutation were identified in both the UK samples from 2017 and the samples from Finland. This shows the mutation is still present in the Norwegian buhund population.

Hereditary cerebellar ataxia appears to be recessive in Norwegian buhunds, according to the AHT. None of the unaffected 146 dogs had two copies of the mutation, whereas all affected dogs that were tested as part of the research had two copies of the mutation.

Dr Cathryn Mellersh, head of canine genetics at the AHT, said: “We’re very happy to be able to help this breed swiftly eliminate any potential carriers, and therefore affected dogs with cerebellar ataxia, and to demonstrate that whole genome sequencing really works as a method of speeding up mutation identification and developing new DNA tests.”

The DNA test can be ordered from: www.ahtdnatesting.co.uk

Image courtesy of AHT

 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.